Log In
Print this Print this

icaritin (SNG-162)

  Manage Alerts
Collapse Summary General Information
Company Shenogen Pharma Group Ltd.
DescriptionSmall molecule derived from a Chinese herb targeting estrogen receptor alpha 36
Molecular Target Estrogen receptor alpha 36
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationLiver cancer
Indication DetailsTreat hepatocellular carcinoma (HCC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today